Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables

Cinzia Masserini, Antonio Vita, Roberto Basile, Raffaele Morselli, Paolo Boato, Cinzia Peruzzi, Luigi Pugnetti, Pasquale Ferrante, Carlo Lorenzo Cazzullo

Research output: Contribution to journalArticlepeer-review

Abstract

Peripheral blood lymphocyte subsets and serum immunoglobulin levels were assessed in 42 patients and 37 healthy controls. 24 patients were free from neuroleptic medication and 15 had never been treated with neuroleptics. 31 patients had a diagnosis of schizophrenia (DSM-III criteria) and 11 a diagnosis of a disorder of the schizophrenic spectrum. As compared to healthy subjects, the drug naive schizophrenic patient group showed an increase of T suppressor lymphocytes, while the drug-treated schizophrenic group showed an increase of T helper lymphocytes. The drug-treated schizophrenic group differed from the drug naive one relative to a decrease of T suppressor lymphocytes. As compared to healthy subjects, the drug naive spectrum disorder patients showed an increase of absolute number of lymphocytes, while the drug treated spectrum group showed an increase of B lymphocytes. These findings did not correlate with any clinical or neuromorphological variables taken into account.

Original languageEnglish
Pages (from-to)269-275
Number of pages7
JournalSchizophrenia Research
Volume3
Issue number4
DOIs
Publication statusPublished - 1990

Keywords

  • Immunoglobubin
  • Lymphocyte subset
  • Neuroleptic side effect
  • Schizophrenic disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Fingerprint Dive into the research topics of 'Lymphocyte subsets in schizophrenic disorders. relationship with clinical, neuromorphological and treatment variables'. Together they form a unique fingerprint.

Cite this